DEDN6526A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DEDN6526A, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DEDN6526A in Patients With Metastatic or Unresectable Melanoma [Phase 1]